Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

BIAF Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: June 08, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for bioAffinity Technologies Inc (BIAF)

Based on 6 analysts giving stock ratings to bioAffinity Technologies Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
0
Buy
0
Hold
50
Sell
17
Strong Sell
33
bioAffinity Technologies Inc

bioAffinity Technologies Inc. Stock Analysis BIAF

United States Health Care Nano Cap Report:
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The company is headquartered in San Antonio, Texas and currently employs 57 full-time employees. The company went IPO on 2022-08-26. The company develops noninvasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis developed by machine learning, a form of artificial intelligence (AI). The Company’s product, CyPath Lung, is a noninvasive test that has shown high sensitivity, specificity and accuracy for the detection of early-stage lung cancer. CyPath is marketed as a Laboratory Developed Test (LDT) by Precision Pathology Laboratory Services, a subsidiary of the Company. CyPath Lung uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor.
Read More

bioAffinity Technologies Inc (BIAF) Chart

Key Statistics of bioAffinity Technologies Inc (BIAF)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.82$0.85

Today's Open

$0.82

Volume

590.50K

P/E Ratio (TTM)

-

52 Week Range

$0.69$13.80

Market Cap

7.35M

Avg. Volume

521.68K

Dividend Yield

-

Financial Metrics & Statements of bioAffinity Technologies Inc (BIAF)

FAQ's for bioAffinity Technologies Inc (BIAF)

  • According to Musaffa’s Shariah screening methodology, bioAffinity Technologies Inc (BIAF) is currently classified as HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes bioAffinity Technologies Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in bioAffinity Technologies Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of bioAffinity Technologies Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of bioAffinity Technologies Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of bioAffinity Technologies Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.